⌘K

Home/Filings/4/0001062993-20-001377

4//SEC Filing

Chao Jennifer M 4

Accession 0001062993-20-001377

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:06 PM ET

Size

5.2 KB

Accession

0001062993-20-001377

Insider Transaction Report

Form 4

Period: 2020-03-13

BIOSPECIFICS TECHNOLOGIES CORPBSTC

Chao Jennifer M

Director

Transactions

Award
Stock Option (Right to Buy)
2020-03-13+5,000→ 5,000 total
Exercise: $55.62Exp: 2020-03-13→ Common Stock (5,000 underlying)

Footnotes (2)

[F1]The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
[F2]The stock options vest ratably over the one-year period following the date of grant, March 13, 2020.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001639625

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 5:06 PM ET
Size: 5.2 KB

View on SEC.gov